All News

Medical Devices; Orthopedic Devices; Classification of Posterior Cervical Screw Systems

A Proposed Rule by the Food and Drug Administration This document has a comment period that ends in 88 days (06/08/2016)SUBMIT A FORMAL COMMENT ACTION: Proposed Rule. SUMMARY The Food and Drug Administration (FDA or Agency) is proposing to classify posterior cervical screw systems into class II (special controls) and to continue to require premarket notification […]

Medicrea® Celebrates 500 UNID Surgeries and Launches Real-Time Support for Patient-Specific Spine Surgery

LYON, France & NEW YORK–(BUSINESS WIRE)–MEDICREA® (Paris:ALMED) (Alternext Paris: FR0004178572-ALMED), the leading medical device company for developing patient-specific solutions for the treatment of spinal conditions) has announced the groundbreaking UNiD Lab Services have been used in more than 500 surgeries worldwide. UNiD™ Lab Services include a real-time support team to surgeons in the pre-operative planning […]

Maxx Orthopedics Announces First Surgeries with Freedom® PCK Revision System

 PLYMOUTH MEETING, PA (PRWEB) MARCH 10, 2016 On the heels of a successful launch at the 2016 AAOS Annual Meeting last week, Maxx Orthopedics, Inc., today announced the first surgeries performed using the PCK Components. The Freedom® revision system combines the Freedom Stemmed Tibial components with the patent-pending PCK femoral components and constrained liners, to […]

NUVASIVE, INC. ANNOUNCES PRICING OF OFFERING OF $550 MILLION OF 2.25% CONVERTIBLE SENIOR NOTES DUE 2021

SAN DIEGO, CA – March 11, 2016 — NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering of $550,000,000 aggregate principal amount of 2.25% Convertible Senior Notes due 2021 (the “Convertible Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the […]

Lattice Biologics First Quarter 2016 Highlights

Lattice Biologics Ltd. (TSX VENTURE: LBL)(“Lattice Biologics” or the “Company”) announces financial results for the first quarter ended December 31, 2015: First Quarter Financial Results (all figures denoted in USD): Lattice Biologics revenue increased to $1,065,654 in the three months ended December 31, 2015. This is compared to $1,037,040 in the three months ended September […]

Can a total knee arthroplasty be both rotationally unconstrained and anteroposteriorly stabilised?

A pulsed fluoroscopic investigation G. Scott, M. A. Imam, A. Eifert, M. A. R. Freeman, V. Pinskerova, R. E. Field, J. Skinner, S. A. Banks Abstract Objectives Throughout the 20th Century, it has been postulated that the knee moves on the basis of a four-bar link mechanism composed of the cruciate ligaments, the femur and […]

Stryker closes $3.5B notes offering

Stryker (NYSE:SYK) said today that it closed a senior notes offering worth $3.5 billion. The 4-tranche flotation consisted of $750 million in 3-year, 2.0% fixed notes due in March 2019; $750 million in 5-year 2.625% fixed notes due in March 2021; $1.0 billion in 10-year 3.5% fixed notes due in March 2026; and another $1.0 billion in 30-year 4.625% fixed notes due in […]

Ralph Larsen, Ex-CEO Who Expanded Johnson & Johnson, Dies at 77

Stephen Miller obitsman Michelle Cortez FayCortez Ralph Larsen, the former chief executive officer at Johnson & Johnson whose strategy of growth through acquisitions propelled the company to become the nation’s fourth-largest maker of prescription drugs and the world’s biggest provider of medical supplies and devices by the time he stepped down in 2002, has died. […]

Medical students demand an end to pricey exam testing patient care skills

By JENNIFER ANYAEGBUNAM Thousands of medical students across the country are demanding the elimination of a licensing exam that tests their patient care skills, arguing that it’s an expensive waste of time. Led by students from Harvard Medical School, the effort has drawn strong support nationwide. More than 6,000 students, residents, and faculty at 130 medical […]

FDA ORTHO PANEL TO VOTE ON CARTIVA SYNTHETIC CARTILAGE IMPLANT

Walter Eisner The FDA’s Orthopaedic and Rehabilitation Devices Panel will meet on April 20, 2016 to discuss, make recommendations, and vote on the premarket approval application (PMA) for the Cartiva Synthetic Cartilage Implant (SCI), sponsored by Cartiva, Inc. Cartiva’s implant is an organic polymer-based biomaterial to mimic biologic cartilage. The device, according to an FDA […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1